Abstract
Objective: To study the acute effect of clonidine, an α2-adrenoceptor agonist, and yohimbine, an α2-adrenoceptor antagonist, on nocturnal sleep in healthy men.
Setting:
McGuire Veteran Affairs Medical Center, Richmond, Virginia, USA.
Subjects:
Eight healthy male volunteers.
Methods:
Each subject slept in the sleep laboratory for 2 consecutive nights on three separate sessions, at 3-week intervals. On the 2nd night of each session, the subjects received yohimbine (5.4 mg), clonidine (0.1 mg), or placebo in a double-blind, randomized, placebo-controlled, crossover design.
Results:
There were no apparent effects of yohimbine. In contrast, clonidine completely suppressed rapid eye movement (REM) sleep in one subject and reduced REM sleep in the remaining seven subjects.
Conclusion:
Our study confirms that clonidine markedly decreases REM, even at a low single dose, and supports the hypothesis of the important role of α2-receptors in controlling REM sleep.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Author information
Authors and Affiliations
Additional information
Received: 11 August 1995/Accepted in revised form: 2 January 1996
Rights and permissions
About this article
Cite this article
Gentili, A., Godschalk, M., Gheorghiu, D. et al. Effect of clonidine and yohimbine on sleep in healthy men: a double-blind, randomized, controlled trial. E J Clin Pharmacol 50, 463–465 (1996). https://doi.org/10.1007/s002280050141
Issue Date:
DOI: https://doi.org/10.1007/s002280050141